Sight Sciences, Inc.
Clinical trials sponsored by Sight Sciences, Inc., explained in plain language.
-
Second treatment tested to keep dry eyes at bay
Disease control CompletedThis study looked at giving a second treatment with the TearCare System to people with dry eye syndrome who had already received it once. The goal was to see if getting the treatment again was safe and helped control dry eye symptoms for a longer period. Researchers followed 12 p…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Apr 02, 2026 04:56 UTC
-
15-Minute In-Office treatment tested for dry eye relief
Symptom relief CompletedThis study tested a single, 15-minute in-office treatment called the TearCare System to see if it could safely improve dry eye symptoms. Twenty-nine adults with moderate to severe dry eye received the treatment and were followed for one month. The goal was to see if the procedure…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Device challenges popular eye drops in battle against dry eye
Symptom relief CompletedThis study tested whether the TearCare system, a device that applies controlled heat to the eyelids, works as well as or better than Restasis eye drops for treating dry eye disease. It involved 345 adults with moderate to severe dry eye symptoms. Researchers compared how much eac…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
New dry eye device tested against standard treatment
Symptom relief CompletedThis study tested whether the TearCare System is safe and effective for treating dry eye disease. It directly compared a single TearCare treatment to a single LipiFlow treatment in 235 adults with dry eye symptoms. The goal was to see if TearCare could relieve symptoms like eye d…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Quick clinic treatment tested for dry eye relief
Symptom relief CompletedThis small, completed pilot study compared a single 12-minute in-office eyelid treatment (TearCare) to 4 weeks of daily 5-minute warm compress therapy for adults with dry eye disease. The goal was to see if the brief TearCare procedure was a safe and effective alternative to the …
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Mar 19, 2026 14:55 UTC